Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-24-000078 General Corporate
Debt relative to revenue 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
145.80% · OPTIONAL · VALID
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.68% · OPTIONAL · VALID
Operating cash generation 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
18.49% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-2.66% · CORE · VALID
Inventory pressure 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
65.79% · OPTIONAL · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
3.33% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.17% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.77% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 127.90%
Current 145.80%
Delta 17.90% Capex Intensity Increased
Previous 7.25%
Current 7.68%
Delta 0.43% Cash Generation Decreased
Previous 19.41%
Current 18.49%
Delta -0.92% Growth Decreased
Previous -1.86%
Current -2.66%
Delta -0.81% Inventory Pressure Increased
Previous 55.89%
Current 65.79%
Delta 9.90% Profitability Decreased
Previous 8.90%
Current 3.33%
Delta -5.57% R And D Intensity Decreased
Previous 2.33%
Current 2.17%
Delta -0.16% Sbc Intensity Increased
Previous 0.60%
Current 0.77%
Delta 0.17% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.